BioArctic revenue and financials

BIOA.B · Nasdaq Stockholm · SEK

Compare BioArctic
kr 300.60Change from previous close: −1.83%Absolute change: −kr 5.60

Close · November 20, 2026

In the fiscal year ended December 2025, BioArctic reported revenue of kr 2B (+676.80% year over year). Net income was kr 1.02B, a net margin of 51.1%.

Annual revenue · 2025: kr 2B
  1. kr 105.61M2016
  2. kr 156.83M2017
  3. kr 722.22M2018
  4. kr 282.94M2019
  5. kr 65.21M2020
  6. kr 25.66M2021
  7. kr 229.43M2022
  8. kr 616M2023
  9. kr 257.35M2024
  10. kr 2B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+676.80%
2025 vs 2024
Net margin
51.1%
2024: -68.8%

How BioArctic is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of SEK; per-share values in SEK; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue1,99925761622925.765.2283722157106
Cost of revenue59.227.015.074.355.150.272.414563.60.2
Gross profit1,940230601155-29.415.021157793.2105
Selling, general and administrative19514917214997.486.390.989.069.115.9
Research and development377311172——————53.7
Operating income1,368-230257-7.9-140-82.311148624.062.7
EBIT1,368-230257-7.9-140-82.311148624.062.7
EBITDA1,270-211275-1.9-135-78.511448826.064.2
Interest expense2.00.00.30.60.81.01.21.40.60.0
Pre-tax income1,256-190276-11.2-141-86.711349019.774.1
Income tax233-12.447.20.0-20.7-18.224.51084.516.6
Net income1,022-177229-11.2-120-68.588.538215.257.6
Net income to common shareholders1,022-177229-11.2-120-68.588.538215.257.6
Basic EPS11.55-2.002.60-0.13-1.36-0.781.004.330.220.91
Diluted EPS11.52-2.002.59-0.13-1.36-0.781.004.330.220.91
Average shares (basic)88.588.388.288.188.188.188.188.168.163.1
Average shares (diluted)88.788.588.588.788.188.188.188.168.163.1
Dividend per share2.00——————1.50——

Companies in the group: same industry, similar size